• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Isis Pharmaceuticals Inc

+ Add to Watchlist


40.9800 USD 0.2000 0.49%

As of 15:08:45 ET on 10/21/2014.

Snapshot for Isis Pharmaceuticals Inc (ISIS)

Open: 41.7500 Day's Range: 40.5000 - 41.8700 Volume: 1,284,784
Previous Close: 41.1800 52wk Range: 22.2500 - 62.6600 1-Yr Rtn: +27.74%

Stock Chart for ISIS

No chart data available.
  • ISIS:US 40.9800
  • 1D
  • 1M
  • 1Y
Interactive ISIS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ISIS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7994
Est. EPS (USD) (12/2014) -0.7420
Est. PEG Ratio -
Market Cap (M USD) 4,879.35
Shares Outstanding (M) 117.74
30 Day Average Volume 2,347,970
Price/Book (mrq) 13.1443
Price/Sale (ttm) 31.6628
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ISIS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ISIS

Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis' broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.

Stanley T Crooke "Stan"Chairman/President/CEO/FounderB Lynne ParshallCOO/Secretary
Elizabeth L HougenSenior VP:Finance/CFOPatrick R O'NeilSenior VP:Legal/Gen Counsel
More Company Profile & Key Executives for ISIS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil